RPRX
Royalty Pharma·NASDAQ
--
--(--)
--
--(--)
4.06 / 10
Netural
Technical score is 4.06 (neutral). MACD Death Cross provides a bullish bias (score 8.05, 75% win rate), whereas RSI is overbought (score 1.44, bearish) and MACD Golden Cross is weak (score 2.68). Overall signals are mixed, indicating volatility and no clear direction.
Analysis Checks(1/3)
RSI Overbought
Score1.44/10
Win Rate38.89%
Hist. Signals18
Avg Return-0.59%
Score1.44/10
Win Rate38.89%
Hist. Signals18
Avg Return-0.59%
MACD Golden Cross
Score2.68/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.54%
Score2.68/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.54%
MACD Death Cross
Score8.05/10
Win Rate75.00%
Hist. Signals12
Avg Return1.30%
Score8.05/10
Win Rate75.00%
Hist. Signals12
Avg Return1.30%
RSI Overbought
Score1.44/10
Win Rate38.89%
Hist. Signals18
Avg Return-0.59%
Score1.44/10
Win Rate38.89%
Hist. Signals18
Avg Return-0.59%
MACD Death Cross
Score8.05/10
Win Rate75.00%
Hist. Signals12
Avg Return1.30%
Score8.05/10
Win Rate75.00%
Hist. Signals12
Avg Return1.30%
MACD Golden Cross
Score2.68/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.54%
Score2.68/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.54%
Technical Analysis of RPRX?
- RPRX presents a Netural setup with a Technical Score of 4.06/10. Key technical indicators highlight an RSI of 56.81 and a MACD of -0.14, with the trend anchored by the 50-Day SMA at 44.31. Traders should monitor key support at 46.66 and resistance at 47.38.
